By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cellectis 

8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a


SEARCH JOBS


Key Statistics


Email: mail@cellectis.com
Ownership: Public

Web Site: Cellectis
Employees:
Symbol: CLLS
 



Industry
Biotechnology

Segment
Genomics





Company News
No Looking Back: Cellectis (CLLS) Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial 2/7/2017 6:44:43 AM
FDA Grants Cellectis (ALCLS) IND Approval To Proceed With The Clinical Development Of UCART123, The First Gene Edited Off-The-Shelf CAR T-Cell Product Candidate Developed In The U.S. 2/7/2017 6:35:04 AM
Scientists Highlight the Hopes and Fears of Cellectis (ALCLS)' CAR-T 1/26/2017 6:02:54 AM
Cellectis (ALCLS) Release: Four Prominent Physicians To Join Clinical Advisory Board 1/24/2017 8:28:00 AM
Cellectis (ALCLS) Release: Biopharma Studies Safety in New CAR Architecture Controlling CAR T-Cell Functions 1/23/2017 7:26:07 AM
Cellectis (ALCLS) Submits IND Application For UCART123, An Allogeneic Gene Edited CAR T-Cell Product Candidate, In AML And BPDCN 1/4/2017 10:00:50 AM
Cellectis (ALCLS) Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval Of UCART123 Phase 1 Study Protocols In AML And BPDCN 12/16/2016 11:38:43 AM
New York’s Cellectis (ALCLS) Looks to 2017 for Clinical Trials of AML Treatment 12/15/2016 5:19:04 PM
Cellectis (ALCLS) Reports Financial Results For 3rd Quarter And First Nine Months 2016 11/23/2016 8:05:45 AM
Cellectis (ALCLS) Announces Successful cGMP Manufacturing For Second Product Candidate: UCART123 11/16/2016 12:28:31 PM
12345678910...
//-->